Quadrature Capital Ltd Invests $1.11 Million in Nutex Health Inc. $NUTX

Quadrature Capital Ltd purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX) in the second quarter, according to its most recent filing with the SEC. The fund purchased 8,909 shares of the company’s stock, valued at approximately $1,109,000.

Several other large investors have also recently added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System acquired a new position in Nutex Health in the second quarter worth $266,000. XTX Topco Ltd bought a new position in shares of Nutex Health in the 2nd quarter worth about $208,000. CreativeOne Wealth LLC acquired a new position in shares of Nutex Health in the 2nd quarter valued at about $434,000. Ameritas Investment Partners Inc. bought a new stake in shares of Nutex Health during the 2nd quarter valued at about $44,000. Finally, Sierra Summit Advisors LLC acquired a new stake in Nutex Health during the second quarter worth about $562,000. 5.32% of the stock is currently owned by institutional investors.

Insider Transactions at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates purchased 750 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The stock was bought at an average price of $136.71 per share, with a total value of $102,532.50. Following the completion of the purchase, the chief financial officer owned 5,638 shares in the company, valued at $770,770.98. This trade represents a 15.34% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 36.92% of the company’s stock.

Nutex Health Price Performance

Shares of NASDAQ:NUTX opened at $117.28 on Monday. The firm’s 50 day moving average is $112.98 and its two-hundred day moving average is $113.04. The firm has a market capitalization of $829.40 million, a P/E ratio of 9.86 and a beta of -0.23. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02. Nutex Health Inc. has a 52 week low of $28.12 and a 52 week high of $184.27.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($5.43) by $13.19. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%.The business had revenue of $243.99 million during the quarter, compared to analyst estimates of $221.93 million.

Wall Street Analyst Weigh In

A number of equities analysts have commented on NUTX shares. Weiss Ratings upgraded Nutex Health from a “sell (d)” rating to a “hold (c)” rating in a research note on Tuesday, November 25th. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday. Finally, Maxim Group set a $205.00 price objective on Nutex Health and gave the stock a “buy” rating in a research note on Tuesday, August 26th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $252.50.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.